Innate Historical Valuation
| IPHA Stock | USD 1.69 0.02 1.20% |
Some fundamental drivers such as market cap or Innate Pharma enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Innate Pharma valuation indicators such as Enterprise Value of 170 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Innate Pharma's future value.
Innate |
About Innate Valuation Data Analysis
Valuation is the financial process of determining what Innate Pharma is worth. Innate Pharma valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Innate Pharma valuation ratios help investors to determine whether Innate Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innate with respect to the benefits of owning Innate Pharma security.
Innate Pharma Valuation Data Chart
Working Capital
The difference between a company's current assets and current liabilities, indicating the liquidity and operational efficiency of the business.Enterprise Value
Enterprise Value (or EV) is usually referred to as Innate Pharma theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Innate Pharma debt, but would also pocket its cash. Enterprise Value is more accurate representation of Innate Pharma value than its market capitalization because it takes into account all of Innate Pharma existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innate Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Innate Stock refer to our How to Trade Innate Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innate Pharma. If investors know Innate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innate Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.75) | Earnings Share (0.44) | Revenue Per Share | Quarterly Revenue Growth (0.69) | Return On Assets |
The market value of Innate Pharma is measured differently than its book value, which is the value of Innate that is recorded on the company's balance sheet. Investors also form their own opinion of Innate Pharma's value that differs from its market value or its book value, called intrinsic value, which is Innate Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innate Pharma's market value can be influenced by many factors that don't directly affect Innate Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innate Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innate Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innate Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.